The three kindlins exhibit similar distributions within cells but distinct tissue distributions. These patterns suggest that the kindlins may have overlapping functions Purpose of review There are three kindlin family members in vertebrates, which have high-sequence homology and a common organization signature with a C-terminal 4.1, ezrin, radixin, moesin (FERM) domain bisected by a pleckstrin-homology domain. Although the cell and tissue distributions of the three kindlins differ, there is a consistent and close interrelationship between kindlins and integrins, and alterations of kindlin expression affect integrin-dependent functions. However, in-vivo data on the functions of the kindlins and their mechanisms of action have been lacking.
Introduction
Whereas scientific investigation usually provides insights that simplify our understanding of biological processes, in the case of integrin activation, the mechanisms have become more complicated by recent discoveries. One such complication comes from recent studies which have unequivocally implicated the three members of the kindlin family of intracellular proteins as key regulators of integrin activation. This review summarizes recent information on the kindlin family and their role in integrin function based upon observations made in cells, animals and humans.
The kindlin family
The kindlins are a family of structurally similar and evolutionarily conserved intracellular proteins. In mammals, there are three kindlin family members, which are designated as kindlin-1, kindlin-2 and kindlin-3. The kindlin name derives from Theresa Kindler, who described a patient in 1954 with symptoms that included congenital skin blistering, skin fragility and sun sensitivity [1] . This rare autosomal recessive disease, now referred to as Kindler syndrome, is caused by mutations in the gene for kindlin-1 [2, 3] . Kindlins are also referred as UNC-related proteins (URPs) based on a Caenorhabditis elegans homolog, UNC112 [4] . In some studies, kindlin-2 also has been referred to as Mig2 and kindlin-1 as kindlerin. Genes encoding the kindlins are termed as KIND and FERMT. Using these various designations in PubMed searches yields about 100 publications on the kindlins, and many are studies on new cases and mutations in Kindler syndrome. However, within the last 18 months, more than 20 publications have appeared. The findings reported in these recent studies have established previously unappreciated functions of the kindlins in mediating cellular responses, in controlling the phenotypes of whole organisms, and in inducing human disease. Among these recent publications is a review of the kindlins and their roles in integrin and matrix biology [5 ] . but exert their effects in a tissue and cell-specific manner. Kindlin-1 is very abundant in skin and intestines and is localized predominantly to keratinocytes [6] . These localizations are consistent with the skin and intestinal symptoms observed in Kindler syndrome. Kindlin-2 is very broadly distributed with particularly high levels in smooth and skeletal muscle cells. Kindlin-3 appears to be confined to cells of hematopoietic origin [6] . Malignant transformation can alter the expression patterns of kindlins. Kindlin-2 expression is altered in breast and leiomyomas [7, 8] , and kindlin-1 is expressed highly in colon and lung tumors [9] .
The absence of UNC112 in C. elegans gives rise to the PAT phenotype, which is also observed when the homologs of the integrin a and b subunits are missing. Indeed, UNC112 colocalizes with PAT-3, the integrin b subunit, and a relationship between kindlin and integrin expression patterns extends to all cells and organisms examined [10] . In mammalian cells, kindlin-1 and kindlin-2 localize to integrin-containing focal adhesion complexes, and kindlin-3 is found in integrin-containing podosomes of hematopoietic cells [6] . As discussed below, this interrelationship depends in part on their direct interaction with the cytoplasmic tails of integrin b subunits and in part on their interaction with other components assembled into these adhesion complexes. Such adhesion complexes change in composition as cells attach, spread and migrate, and the associations of kindlins are likely to change dynamically.
Structural organization of kindlins
The three mammalian kindlins have molecular weights of approximately 75 kDa. The human kindlins exhibit extensive amino acid sequence homology, displaying 50-60% sequence identity, and the sequences are highly conserved across species. The amino acids of the kindlins are organized into the same structural domains, and a representative kindlin is shown in Fig. 1 . In this presumptive structure, a prominent structural feature is a FERM domain. FERM domains, named for their initial demonstration in 4.1, ezrin, radixin and moesin, link cytosolic proteins to membranes, are prevalent in cytoskeletal related proteins, and are organized into three subdomains: F1, F2, and F3 [11] . The kindlin FERM domains are most similar to that in talin [12] . Both talin and kindlin FERM domains mediate binding to the cytoplasmic tails of integrin b subunits and regulate their function. This interaction depends on the F3 subdomain in both proteins, which has the organization of a phosphotyrosine-like binding (PTB) domain [13,14,15 ,16 ] . However, there are several features which distinguish the FERM domains within kindlins from that of talin and other proteins. Whereas the FERM with its PTB subdomain is located in the N-terminal region of talin and most other FERM domain containing proteins, it resides in the C-terminal aspects of the kindlins [5 ] . The prototypic kindlin FERM also lacks a F1 subdomain, and its F2 subdomain is bisected by a pleckstrin-homology domain ( Fig. 1 ). Pleckstrin-homology domains mediate binding of phosphatidylinositides, and the expressed pleckstrin-homology domain of kindlin-2 exhibits this function (unpublished).
Integrins, talin and their activation
As a prelude to recent studies of the kindlins, a very brief consideration of integrins and talin is required. As a family, integrins influence numerous physiological and pathological processes, including cell adhesion, migration and survival, and these functions depend upon their ability to bind ligands within their extracellular environment and link them to the cytoskeleton and/or cytoplasmic signaling machinery within the cell [17] [18] [19] . Each integrin family member is a heterodimer composed of noncovalently linked a and b subunits. There are 8 integrin b subunits and 18 integrin a subunits. Specific a/b subunit combinations determine which extracellular ligands are recognized. The organizational signature of the a and b subunits is similar. Each contains a large extracellular domain (ECD) containing a large globular headpiece, a single pass transmembrane domain and a short cytoplasmic tail of 15-60 amino acids (except b4).
For many integrins, particularly on cells with their integrins exposed to blood, their functions depend on their activation. Integrin activation is defined as the transition from a low (resting state) to a high-affinity state (active state) for their extracellular ligands. This transformation is induced by an inside-out signaling pathway triggered by various cellular agonists. Upon ligand binding and/or clustering of the integrins, outside-in signaling can be initiated to induce events that alter cell shape and function [20, 21] . The cytoplasmic tails of integrins act as transmitters and receivers of the bidirectional signaling across integrins. By alignment of all integrin b cytoplasmic tails, several highly conserved regions are evident ( Fig. 2 ) which have been implicated in integrin activation. These regions are: the membrane proximal region; the first NXXY motif, NPLY 747 , in b3; a distal As currently envisioned, integrins are maintained in a resting state by transmembrane domain-transmembrane domain and cytoplasmic tail-cytoplasmic tail contacts. Dissociation of these intrasubunit interactions drives global movements of the ECD from a bent to an extended conformation and local rearrangements within the ECD to allow access of ligands to a binding pocket comprised of both subunits [19, 22, 23, 24 ] . Nuclear magnetic resonance (NMR) structural studies of a cytoplasmic tail of a prototypical integrin, aIIbb3, suggest that each cytoplasmic tail has a helical structure as it emerges from the membrane into the cytosol [25] [26] [27] . Some but not all of these structural studies suggest that these cytoplasmic tail helices interact. Particularly important in maintaining the cytoplasmic tail complex is a salt bridge that forms between residues D 723 in b3 and R 995 in aIIb. Destabilization of this salt bridge by sitedirected mutagenesis or naturally occurring mutation leads to at least partial integrin activation [28] [29] [30] . Hydrophobic interactions between the cytoplasmic tail helices also have been detected, and mutational data support the role of both electrostatic and hydrophobic bonds in maintaining the cytoplasmic tail complex [25, 29] . The clasp formed between the cytoplasmic tail helices maintains the integrin in a resting state, and disruption leads to activation. Only one NMR structure detected the salt bridge, although a large body of mutational and functional data, including analyses of mutations in humans and mice, supports its existence and its importance in regulating the activation of some but not all integrins [30] [31] [32] . The a and b transmembrane domain also forms helices that interact but their interconnection to the cytoplasmic tail clasp remains to be resolved. [33, 34] . Unclasping of the cytoplasmic tail is likely to induce separation of the transmembrane domain-transmembrane domain helices to propagate the inside-out signal across the cell membrane to the ECD [35, 36] .
A strong and substantial body of evidence indicates that talin, a 270-kDa cytoskeletal protein, is essential for integrin activation [37] [38] [39] [40] . Talin is composed of an N-terminal head (talin-H), which contains a FERM domain, and a long, flexible rod domain (talin-R) [41] . The F3 (PTB) subdomain binds with high affinity to the b cytoplasmic tail and induces integrin activation. The talin F3 subdomain binds to two sites in the b3 cytoplasmic tail, the NPXY turn and the membrane proximal region. The latter interaction disrupts the clasp between the a and b cytoplasmic tail and initiates activation. This mechanism is supported by structure analyses [25, 42] and studies of mice with a point mutation of a talin-binding site [43] . Inherent in this model is the necessity for talin itself to be activated. Such regulation is achieved in two distinct ways, which are identified but not detailed here. First, the cytoskeletal protein filamin acts as a negative regulator [44] . It binds to the b cytoplasmic tail adjacent to the NPXY and impedes access of talin to its binding site. Mechanisms have been identified which displace filamin from its b cytoplasmic tail binding site facilitating integrin activation [45 ,46 ] . Second, intact talin exists in a conformation in which talin-R interacts with talin-H and precludes its binding to the b cytoplasmic tail [47 ,48 ] . The pathway by which this autoinhibition of talin is relieved involves Rap1 and RIAM [49, 50] .
Enter the kindlins
There is also a substantial evidence from theoretical considerations, mutational data and in-vivo data from humans and mice that regions of the b cytoplasmic tail not directly involved in talin-H binding are critical to integrin activation. As a pivotal example, a naturally occurring mutation of S 752 P in the b3 cytoplasmic tail, a mutation that does not affect talin-H binding, gives rise to Glanzmann's thrombasthenia caused by a nonactivatable aIIbb3 on platelets [51] . Numerous binding partners for the b cytoplasmic tail have been identified which might account for C-terminal region involvement, and kindlin-1 and kindlin-2 were among these. Kindlin-1 had been identified as a transforming growth factor (TGF)-b inducible gene that associated with the b1 and b3 cytoplasmic tail and influences cell spreading [12] . Kindlin-2 also associates with the b1 and b3 cytoplasmic tail, to strengthen the adhesion of cells and to control focal adhesion formation [52] . Two studies published in 2008 demonstrated that kindlin-2 had minimal activating activity but when coexpressed with talin-H led to synergistic activation of aIIbb3 [53 ,54 ] . These studies both showed that this coactivating activity depended on binding of kindlin-2 to the b3 cytoplasmic tail. This interaction required a functional PTB-like binding domain in kindlin-2 since mutations in this structure QW 614/615 AA prevented interaction and integrin coactivation. However, rather than binding to the NPLY 747 turn in the b3 cytoplasmic tail to which talin binds with high affinity, kindlin-2 binding depended on the membrane distal NITY 759 . Kindlin-2 binding also was abrogated by the S 752 P mutation, providing a potential explanation for the nonactivatable state of the integrin bearing this mutation. Studies of kindlin-1 [55 ] and kindlin-3 [16 ] provide evidence for similar structure-function relationships. The C-terminal NXXY motifs in b1, b2 and b3 were shown to be required for interaction with the kindlins, and a single point mutation at Q or W in the PTB domains of kindlins blocked integrin binding and coactivator function [55 ] . However, the structure-function relationships in the kindlin/integrin interface are more complex; deletion of the N-terminal region of kindlin-2 or kindlin-3 blocks integrin-activating activity even though its PTB is intact [53 ,56 ] . Furthermore, kindlin-1 and kindlin-2bearing mutations that prevent integrin binding exert a negative effect on cell adhesion [55 ].
Deficiencies of kindlins in fish, mice and humans
Loss of kindlin-1 in humans causes Kindler syndrome, with the most common characteristics being congenital skin blistering and poikiloderma, and there is often oral and colonic involvement [2] . Histologically, the blisters show epithelial detachment from the underlying tissue. Deletion of kindlin-1 in mice also gives rise to skin as well as intestinal defects [57 ] . The intestinal defect has been attributed to defective integrin activation in epithelial cells. Human deficiencies of kindlin-2 have not been reported and are predicted to be embryonically lethal since knock-out of kindlin-2 in mice and zebrafish results in embryonic lethality [54 ,58 ] . The phenotypes of the embryos in both species are consistent with defective integrin function, exerting a prominent effect on cardiac development and function. The specific role of kindlin-2 in myogenesis relates to its regulation of myocyte elongation [59 ] . Again, phenotypes could be assigned to effects of kindlin-2 on integrin function, and cells derived from the kindlin-2À/À mice or in which kindlin-2 was knocked down by siRNA point to its prominent role in integrin activation [53 ,54 ] . Knock-out of kindlin-3 is not embryonically lethal but the mice only survive for 1 week [16 ] . Initial characterization of the kindlin-3À/À mice was restricted to its role in plateletdependent responses. Platelets from these mice did not aggregate due to a failure to activate aIIbb3 and consequently the mice failed to form a thrombus in an FeCl 3 model. In a subsequent study, leukocyte transmigration was shown to be blunted in the kindlin-3À/À mice [60 ] . The leukocytes were able to roll on endothelium but were unable to adhere firmly, a response requiring b2 integrins and their activation. Kindlin-3 deficiency in mice was also reported to lead to an abnormal morphology of erythrocytes [61 ] and this may reflect integrin-independent functions of this kindlin.
Within the past year, mutations in kindlin-3 have been linked to a human disease [56 ,62 ,63 ] . The common symptoms in the patients are bleeding and susceptibility to infections, and it is likely that osteopetrosis is common to this disease. Platelets from these patients fail to aggregate, leukocytes fail to spread properly, and mesenchymal cells produce excessive amounts of bone and cartilage. This disease has been referred to as leukocyte adhesion deficiency-III (LADIII) [64, 65] or LADI variant (LADIv) [63 ] and integrin activation deficiency disease (IADD) [56 ] . We coined that latter designation since either LAD designation failed to capture the most troublesome phenotype in our patients, their bleeding symptom, which was related to their aberrant platelet function and required multiple transfusions [56 ] . The defect in some patients with these symptoms had been ascribed to mutations in their CALDAG-GEF1 protein, a guaninine exchange factor for Rap1; and mice deficient in CALDAG-GEF1 do display certain defects in activation of platelet and leukocyte integrins [66] and were regarded as a model for LADIII [67] . More careful analysis, however, revealed that many of the patients lack mutations in CALDAG-GEF1 but all carry stop-codon mutations in the kindlin-3 gene [63 ] . In fact, CALDAG-GEF1 protein and function were normal in many patients and kindlin-3 but not CALDAG-GEF1 rescued the abnormal phenotype of immortalized cells from the patients [56 ,62 ] . Thus, the defects in the patients were caused by the lack of kindlin-3 and unrelated to CALDAG-GEF1 function. The disease symptoms in these patients are consistent with the restricted expression of kindlin-3 to hematopoietic tissues, as is the reversibility of the IADD symptoms by bone marrow transplantation. Also of note, erythrocyte shape abnormalities observed in the kindlin-3À/À mice [61 ] were not detected in IADD patients; that is, mice and human may not be identical. However, humans and mice with nonfunctional kindlin-3 did show abnormal leukocyte functions due to dysfunctional b2 integrins [60 ] .
Conclusion
Recent publications clearly implicate the kindlins as novel regulators of integrin-mediated responses. One mechanism by which kindlins influence cellular responses is by synergizing with talin to activate integrins, a function that depends on their direct binding to the cytoplasmic tails of integrin b subunits. Kindlins may influence cell adhesive responses in ways that may depend on still other binding partners. The demonstrations that animals with inactivated genes for the kindlins display lethal phenotypes and that human diseases arise from kindlin mutations add legitimacy and importance to analyses of their structure and function.
